Back HIV/AIDS HIV/AIDS Topics HIV-Related Conditions

CROI 2014: Neurocognitive Problems, Depression, and Early ART in People with HIV

In a particularly challenging area of HIV care where research is complicated by gaps in knowledge and invasive clinical procedures, there was significant attention to neurological manifestations -- or neuroAIDS -- at this year’s Conference on Antiretroviral Agents and Chemotherapy (CROI 2014) last month in Boston.

alt

Read more:

CROI 2014: Researchers Discuss HIV, Aging, and Frailty

People living with HIV are at greater risk of geriatric syndromes such as frailty and difficulty with daily activities than HIV negative people of the same age -- and this can have a significant effect upon their quality of life as they age, according to several studies presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI 2014) last month in Boston.

alt

Read more:

CROI 2014: People with HIV More Likely to Die of Many Common Cancers

People with HIV are more likely to die from many common cancers than the rest of the U.S. population, according to a large comparative study presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this month in Boston.

alt

Read more:

Men with HIV Have Higher Risk of Heart Disease

HIV positive men have more extensive atherosclerosis, or build-up of plaque in their arteries, than HIV negative men after taking into account other cardiovascular risk factors, potentially raising the risk of heart attack, according to an analysis from the large MACS cohort published in the April 1 Annals of Internal Medicine.

alt

Read more:

CROI 2014: Heart Attack Risk May Be Falling for People with HIV -- But Not for Women

A number of studies at last week’s 21st Conference on Retroviruses and Opportunistic Infections in Boston examined whether people with HIV have an elevated risk of heart attack and other manifestations of cardiovascular disease  (CVD). They came to different conclusions about whether having HIV is in itself a cardiovascular risk factor.

alt

Read more:

CROI 2014: Heart Attack Link to Abacavir Persists in D:A:D Study

The nucleoside reverse transcriptase inhibitor abacavir (Ziagen, also in Epzicom or Kivexa) continues to be associated with a near-doubling of the risk of heart attack, according to the latest update from the Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study, presented to the 21st Conference on Retroviruses and Opportunistic Infections (CROI) this month in Boston.

alt

Read more:

Coverage of the 2014 Conference on Retroviruses and Opportunistic Infections

HIVandHepatitis.com coverage of the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014), March 3-6, 2014, in Boston.

Conference highlights include new treatments for hepatitis C, HIV experimental therapies and treatment strategies, HIV cure research, HIV-related conditions, treatment as prevention and PrEP, and HIV/HCV coinfection.

Full listing by topic

Selected presentations and slide webcasts 

3/9/14

alt

CROI 2014: Newborns Exposed to Tenofovir Have Lower Bone Content [VIDEO]

Infants born to women who took tenofovir during pregnancy had significantly lower bone mineral content than babies who were not exposed, according to study findings reported at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this month in Boston.

alt

Coverage of the 2014 Conference on Retroviruses and Opportunistic Infections

HIVandHepatitis.com coverage of the 21st Conference on Retroviruses and Opportunistic infections (CROI 2014), March 3-6, 2014, in Boston.

Conference highlights include new treatments for hepatitis C, HIV experimental therapies and treatment strategies, HIV cure research, HIV-related conditions, treatment as prevention and PrEP, and HIV/HCV coinfection.

Full HIVandHepatitis.com coverage by topic

Selected presentations and slide webcasts 

3/9/14

alt